Danko Georgiev
Danko D. Georgiev earned his M.D. from Medical University of Varna, Bulgaria, in 2004, and his Ph.D. in Pharmaceutical Sciences from Kanazawa University, Japan, in 2008 for his research in the area of neuronal differentiation. He has worked as an anesthesiologist at the Naval Hospital, Varna, and was also a researcher in the Department of Psychiatry and Neurobiology at Kanazawa University, where he studied the molecular alterations in the cerebral cortex of subjects with schizophrenia. He held a two-year JSPS Postdoctoral Fellowship awarded by the Japan Society for the Promotion of Science, and was a short-term visiting scholar at the Department of Psychiatry, University of Pittsburgh. He was then a postdoctoral associate in the Department of Environmental and Occupational Health, University of Pittsburgh, where he studied the pathogenesis and treatment of Alzheimer's disease. Dr. Georgiev is currently a principal investigator at the Institute for Advanced Study, Varna, Bulgaria, where he performs interdisciplinary research on quantum foundations, quantum physics, quantum chemistry, neuroscience, information science and applied mathematics.
Address: Varna, Varna, Bulgaria
Address: Varna, Varna, Bulgaria
less
Related Authors
Alin C Cucu
University of Lausanne
Sarita Tamang
University of Delhi
Igor Jerman
University of Ljubljana, Biotechnical Faculty
Dirk K F Meijer
University of Groningen
J. Clarkson
Technical University of Munich
Jack A Tuszynski
University of Alberta
Lester Ingber
Physical Studies Institute
Uploads
Books by Danko Georgiev
of quantum information theory applied to the study of
brain function. It offers a self-study guide to probe the
problems of consciousness, including a concise but rigorous
introduction to classical and quantum information theory,
theoretical neuroscience, and philosophy of the mind. It
aims to address long-standing problems related to
consciousness within the framework of modern theoretical
physics in a comprehensible manner that elucidates the
nature of the mind-body relationship. The reader also gains
an overview of methods for constructing and testing
quantum informational theories of consciousness.
Papers by Danko Georgiev
METHOD: KCNS3 mRNA expression was evaluated by in situ hybridization in 22 matched pairs of schizophrenia and comparison subjects and by microarray analyses of pooled samples of individually dissected neurons that were labeled with Vicia villosa agglutinin (VVA), a parvalbumin neuron-selective marker, in a separate cohort of 14 pairs. Effects of chronic antipsychotic treatments on KCNS3 expression were tested in the prefrontal cortex of antipsychotic-exposed monkeys.
RESULTS: By in situ hybridization, KCNS3 mRNA levels were 23% lower in schizophrenia subjects. At the cellular level, both KCNS3 mRNA-expressing neuron density and KCNS3 mRNA level per neuron were significantly lower. By microarray, KCNS3 mRNA levels were lower by 40% in VVA-labeled neurons from schizophrenia subjects. KCNS3 mRNA levels were not altered in antipsychotic-exposed monkeys.
CONCLUSIONS: These findings reveal lower KCNS3 expression in prefrontal cortical parvalbumin neurons in schizophrenia, providing a molecular basis for compromised detection of coincident synaptic inputs to parvalbumin neurons that could contribute to altered γ-oscillations and impaired cognition in schizophrenia.
of quantum information theory applied to the study of
brain function. It offers a self-study guide to probe the
problems of consciousness, including a concise but rigorous
introduction to classical and quantum information theory,
theoretical neuroscience, and philosophy of the mind. It
aims to address long-standing problems related to
consciousness within the framework of modern theoretical
physics in a comprehensible manner that elucidates the
nature of the mind-body relationship. The reader also gains
an overview of methods for constructing and testing
quantum informational theories of consciousness.
METHOD: KCNS3 mRNA expression was evaluated by in situ hybridization in 22 matched pairs of schizophrenia and comparison subjects and by microarray analyses of pooled samples of individually dissected neurons that were labeled with Vicia villosa agglutinin (VVA), a parvalbumin neuron-selective marker, in a separate cohort of 14 pairs. Effects of chronic antipsychotic treatments on KCNS3 expression were tested in the prefrontal cortex of antipsychotic-exposed monkeys.
RESULTS: By in situ hybridization, KCNS3 mRNA levels were 23% lower in schizophrenia subjects. At the cellular level, both KCNS3 mRNA-expressing neuron density and KCNS3 mRNA level per neuron were significantly lower. By microarray, KCNS3 mRNA levels were lower by 40% in VVA-labeled neurons from schizophrenia subjects. KCNS3 mRNA levels were not altered in antipsychotic-exposed monkeys.
CONCLUSIONS: These findings reveal lower KCNS3 expression in prefrontal cortical parvalbumin neurons in schizophrenia, providing a molecular basis for compromised detection of coincident synaptic inputs to parvalbumin neurons that could contribute to altered γ-oscillations and impaired cognition in schizophrenia.